Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical PET imaging--an Asian perspective.

C L Ho1

  • 1Department of Nuclear Medicine & Positron Emission Tomography, Hong Kong Sanatorium & Hospital, Hong Kong, SAR China. garrettho@hksh.com

Annals of the Academy of Medicine, Singapore
|April 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal diagnosis of umbilical cord hemangioma.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Isolated intracardiac recurrence of diffuse large B-cell lymphoma successfully treated with rituximab and bendamustine chemotherapy regimen.

Journal of postgraduate medicine·2020
Same author

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Investigation of availability and accessibility of community automated external defibrillators in a territory in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2014
Same author

Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.

QJM : monthly journal of the Association of Physicians·2013
Same author

Blue-black discoloration of the nails associated with gefitinib.

Acta clinica Belgica·2011

Positron emission tomography-computed tomography (PET-CT) is vital in oncology, but F-18 fluorodeoxyglucose (FDG) PET-CT has limitations. Research into new PET radiopharmaceuticals is crucial for improving cancer diagnosis, especially in Asian populations prone to false negatives and positives.

Area of Science:

  • Medical Imaging
  • Oncology
  • Radiopharmaceuticals

Background:

  • Positron emission tomography-computed tomography (PET-CT) has advanced significantly, offering integrated functional and anatomical imaging for cancer diagnosis, staging, and treatment monitoring.
  • While F-18 fluorodeoxyglucose (FDG) is a widely used PET radiopharmaceutical, its efficacy varies across cancer types and populations.
  • Disparities in cancer incidence and prevalence between Asian and Western populations contribute to differential rates of false-negative and false-positive FDG-PET results.

Purpose of the Study:

  • To evaluate the current role and limitations of FDG-PET imaging in oncology.
  • To highlight the challenges posed by population-specific cancer patterns and disease prevalence on PET-CT accuracy.
  • To emphasize the need for developing novel PET radiopharmaceuticals beyond FDG.

Related Experiment Videos

Main Methods:

  • Review of current applications and limitations of PET-CT in oncological imaging.
  • Analysis of FDG-PET performance in various cancer types, considering ethnic and geographic variations.
  • Discussion of factors contributing to false-negative and false-positive results in different populations.

Main Results:

  • FDG-PET-CT is a standard modality for many cancers but shows reduced sensitivity for certain types prevalent in Asia (e.g., hepatocellular, gastric, urological carcinomas).
  • Asian populations face higher risks of both false-negative (due to less FDG-avid cancers) and false-positive (due to prevalent conditions like tuberculosis) PET results.
  • Existing FDG-PET limitations necessitate research into alternative radiopharmaceuticals to improve diagnostic accuracy.

Conclusions:

  • FDG-PET-CT utility in oncology is established but constrained by cancer-specific and population-specific factors.
  • Addressing the higher incidence of false negatives and positives in Asian populations requires dedicated research into new PET agents.
  • Continued development of novel PET radiopharmaceuticals is essential to enhance diagnostic capabilities and overcome FDG limitations in diverse patient groups.